Job Seekers, Welcome to Regulatory Career Connections
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 72 Jobs
Save Agent
Loading... Please wait.
Celldex Therapeutics, Inc

New Haven, Connecticut

Closing Soon! Closing Soon!
ARMI | BioFabUSA

Manchester, New Hampshire

NEW! NEW!
Philips Electronics

Cambridge, Massachusetts

NEW! NEW!
Philips Electronics

Cambridge, Massachusetts

NEW! NEW!
Co-Diagnostics, Inc. Logo
Co-Diagnostics, Inc.

Salt Lake City, Utah

NEW! NEW!
Avanos

Alpharetta , Georgia

Roehm America

Wallingford, Connecticut

Grace Corporation

South Haven, Michigan

Grace Corporation

South Haven, Michigan

MDC Associates, Inc.

Beverly,

Professional Disposables International Logo
Professional Disposables International

Woodcliff Lake, New Jersey

Promega Logo
Promega

Madison, Wisconsin

US Pharmacopeia

Rockville, Maryland

Eisai Logo
Eisai

Woodcliff Lake, New Jersey

UCLA Health Logo
UCLA Health

Los Angeles, California

Mammotome

Cincinnati, Ohio

American Regent

New Albany, Ohio

Philips Electronics

Charlestown, Massachusetts

Closing Soon! Closing Soon!
Allurion Technologies

01760, Massachusetts

Closing Soon! Closing Soon!
DHL Supply Chain Logo
DHL Supply Chain

Westerville, Ohio

Closing Soon! Closing Soon!
Closing Soon! Closing Soon!
Closing Soon! Closing Soon!
Overjet

Boston, Massachusetts

Loading... Please wait.
Job Saved Save Job
Associate Director, Regulatory Affairs
Celldex Therapeutics, Inc
Details

Posted: 26-Aug-21

Location: New Haven, Connecticut

Type: Full Time

Categories:

Quality/Risk Management
Worldwide Regulatory Affairs
Email Print

Internal Number: 1

About Celldex Therapeutics, Inc
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. We are dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (acquired by the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raise...d against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired five companies, folding in five assets, and in-licensed/purchased an additional two assets.
Connections working at Celldex Therapeutics, Inc
Loading. Please wait.
Powered By Naylor Association Solutions
For assistance please call 888.491.8833 or e-mail customerservice+18490@support.boxwoodtech.com